Skip to main content
Morris Barocas on Muck Rack

Morris Barocas

As seen in: Color Research & Application, Medscape
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Morris

Contact Morris, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Vedolizumab Levels and Outcomes in Ulcerative Colitis

|
By Mark Osterman, Maria Rosario, Karen Lasch, Morris Barocas
| Medscape Verified
Abstract and Introduction Abstract Background: Prospectively designed studies assessing the exposure-response profile of vedolizumab are lacking. Observational exposure-response data for vedolizumab are limited and have not been adjusted for potential confounding factors, particularly those that may affect vedolizumab clearance.
Open in Who Shared Issue with article?

Vedolizumab exposure levels and clinical outcomes in ulcerative colitis: determining the potential for dose optimisation

|
By Mark Osterman, Maria Rosario, Karen Lasch, Morris Barocas
| Color Research & Application Verified
Summary Background Prospectively designed studies assessing the exposure‐response profile of vedolizumab are lacking. Observational exposure‐response data for vedolizumab are limited and have not been adjusted for potential confounding factors, particularly those that may affect vedolizumab clearance.
Open in Who Shared Issue with article?
See all 2 articles